SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001393905-20-000237
Filing Date
2020-08-13
Accepted
2020-08-13 14:13:29
Documents
52
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT rtsl_10q.htm 10-Q 236737
2 FORM OF SUBSCRIPTION AGREEMENT rtsl_ex102.htm EX-10.2 68143
3 CERTIFICATION rtsl_ex311.htm EX-31.1 6679
4 CERTIFICATION rtsl_ex312.htm EX-31.2 6679
5 CERTIFICATION rtsl_ex321.htm EX-32.1 3358
6 CERTIFICATION rtsl_ex322.htm EX-32.2 3293
  Complete submission text file 0001393905-20-000237.txt   1428251

Data Files

Seq Description Document Type Size
7 rtsl-20200630.xml EX-101.INS 131128
8 rtsl-20200630.xsd EX-101.SCH 21231
9 rtsl-20200630_cal.xml EX-101.CAL 15621
10 rtsl-20200630_def.xml EX-101.DEF 45153
11 rtsl-20200630_lab.xml EX-101.LAB 116780
12 rtsl-20200630_pre.xml EX-101.PRE 108638
Mailing Address 5580 PETERSON LANE SUITE 200 DALLAS TX 75240
Business Address 5580 PETERSON LANE SUITE 200 DALLAS TX 75240 214-236-1363
Rapid Therapeutic Science Laboratories, Inc. (Filer) CIK: 0001575659 (see all company filings)

IRS No.: 462111820 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-55018 | Film No.: 201098703
SIC: 2834 Pharmaceutical Preparations